Oxidative stress plays pivotal roles in the progression of lung adenocarcinoma (LUAD) through cell signaling related closely to cancer growth. We previously reported that peroxiredoxin 4 (PRDX4), a secretory-type antioxidant enzyme, can protect against the development of various diseases, including potential malignancies. | The combination of weak expression of PRDX4 and very high MIB-1 labelling index independently predicts shorter disease free survival in stage I lung adenocarcinoma
